Phase Genomics wins $3.9M in NIH grants to advance Hi-C and AI tests for chromosomal abnormalities

Seattle biotech Phase Genomics received $3.9 million in NIH grants to fund three-year projects using Hi-C proximity ligation and AI to detect chromosomal abnormalities linked to infertility and cancers.

No comments yet.